ALI Technologies of Vancouver, BC, has introduced version 2.0 of its UltraWeb package, which is designed to provide secure, cost-effective access to medical images and reports over the Internet or an
ALI Technologies of Vancouver, BC, has introduced version 2.0 of its UltraWeb package, which is designed to provide secure, cost-effective access to medical images and reports over the Internet or an intranet with a Windows-based PC and a standard Web browser. Using UltraWeb, healthcare providers gain online access to images stored in the ALI UltraPACS database, regardless of whether they are in the office, at home, or within the hospital. UltraWeb uses Java technology and selectable image compression (wavelet or JPEG), with ratios ranging from 10:1 to 50:1. Users can search the database by patient name, patient ID, or exam date, just as they would from an ALI diagnostic workstation, and have access to the same image manipulation tools.
In related news, ALI has introduced UltraPACS v. 4.2, which includes an Oracle 8i database, advanced search features, and digital video tools.
© 2000 Miller Freeman, Inc., a United News & Media company.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.